Commentary
Harm reduction healthcare: From an alternative to the mainstream platform?

https://doi.org/10.1016/j.drugpo.2010.01.001Get rights and content

Abstract

Despite a plethora of health-related problems, access to primary healthcare is often limited for drug users (DUs). Many seek care at emergency departments and tertiary hospitals because of late presentation of illness. The costs to both DUs and the health system are such that harm reduction based healthcare centres (HRHCs) have been established in various settings and utilising a variety of models. These provide a range of medical and sometimes social services, in one, integrated, low-threshold facility, including (or closely linked with) programs such as needle syringe provision. In some countries these HRHCs are becoming an alternative healthcare system for DUs. However, the need to provide such services on a broad, public health scale, in a sustainable, cost-effective manner, raises the question as to whether such programmes should be mainstreamed. This commentary provides insights on advantages and disadvantages to mainstreaming HRHCs, and approaches and barriers to achieving this. Two approaches suggest themselves: (i) providing harm reduction services through the regular healthcare system, or (ii) more closely integrating HRHCs with mainstream services. Funding and stigma are major barriers to mainstreaming. Diverse national policies towards DUs, healthcare systems and contexts, necessitate different approaches. Because of the various barriers to mainstreaming, any steps towards mainstreaming should be taken whilst maintaining the option of continuing the current targeted harm reduction services.

References (19)

There are more references available in the full text version of this article.

Cited by (20)

  • Alcohol treatment systems in Muslim majority countries: Case study of alcohol treatment policy in Iran

    2020, International Journal of Drug Policy
    Citation Excerpt :

    The very different context in many MMCs may act as barriers to implementing some of these approaches, such as integration of BI into PHC in Iran. It is likely that relevant lessons can be learnt from the experience of attempts to implement screening, BI and treatment for illicit drugs in PHC of western countries (Islam, Day & Conigrave, 2010; Islam, Topp, Conigrave, & Day, 2013). The highly stigmatised status of alcohol makes it difficult to implement several aspects of global alcohol policy.

  • The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature

    2012, International Journal of Drug Policy
    Citation Excerpt :

    Harm reduction is still woefully under-funded (Bergenstrom et al., 2010). It might, therefore, be reasonable to consider the gradual mainstreaming of these services into traditional healthcare delivery (Islam, Day, & Conigrave, 2010). However, achieving mainstreaming is challenging and it is unlikely that there will be a single best answer for all settings due to substantial geographical, cultural, policy and practice variation.

  • Access to harm reduction services in Atlantic Canada: Implications for non-urban residents who inject drugs

    2012, Health and Place
    Citation Excerpt :

    Given the minimal resources of harm reduction organizations, and the remote location of many non-urban communities, one potential solution – that is perhaps more realistic and economically viable – is to integrate harm reduction approaches into existing health and social services. Indeed, harm reduction advocates have identified that it is unlikely that harm reduction can be sufficiently scaled-up to meet current and future needs by replicating existing community-based micro-projects such as NEPs (Islam et al., 2010). Rather, to maximize the positive effects of such initiatives, harm reduction must transition “from the exceptional to the mainstream” (Stimson and O’Hare, 2010, p. 92).

View all citing articles on Scopus
View full text